GEN News Highlights

Expression Analysis to Offer Genomic Services in U.K. through Partnership with Geneblitz

entered a partnership with Complement Genomics, holding company of Geneblitz, to offer its genomic services for clinical trials and research to the U.K. market.

Geneblitz provides a range of services to the biotechnology sector, such as genotyping, DNA sequencing, forensic testing, and a number of toxicology and drug analysis protocols in addition to its own research programs in wound care.

"The partnership with Geneblitz provides us an established presence in the U.K., with an experienced service provider who operates with the same philosophy and similar quality standards and platforms," says Steve McPhail, president and CEO of Expression.

The Geneblitz agreement with its emphasis on genome-wide association studies is reflective of Expression Analysis' growing activity in this area, McPhail adds.

Expression Analysis' genomic services include whole genome to focused-set gene expression and genotyping assays as well as sequencing services.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.